NOVARTIS INDIA
|
NOVARTIS INDIA Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 41.88 | -1.51 | 8.47 | 4.08 | 20.98 |
| CEPS(Rs) | 44.34 | 2.40 | 13.40 | 9.41 | 22.26 |
| DPS(Rs) | 47.50 | 10.00 | 10.00 | 10.00 | 10.00 |
| Book NAV/Share(Rs) | 314.30 | 281.17 | 289.36 | 293.36 | 309.34 |
| Tax Rate(%) | 10.42 | 2.62 | 47.80 | 64.80 | 39.64 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 14.15 | 5.50 | 5.66 | 2.20 | 2.06 |
| EBIT Margin(%) | 25.47 | 0.21 | 10.52 | 6.58 | 14.82 |
| Pre Tax Margin(%) | 25.09 | -0.78 | 8.82 | 5.38 | 14.55 |
| PAT Margin (%) | 22.48 | -0.76 | 4.61 | 1.89 | 8.78 |
| Cash Profit Margin (%) | 23.79 | 1.22 | 7.29 | 4.36 | 9.32 |
| Performance Ratios | |||||
| ROA(%) | 5.09 | -0.18 | 1.22 | 0.62 | 2.51 |
| ROE(%) | 14.07 | -0.53 | 2.91 | 1.36 | 6.89 |
| ROCE(%) | 15.96 | 0.14 | 6.67 | 4.73 | 11.70 |
| Asset Turnover(x) | 0.23 | 0.23 | 0.26 | 0.33 | 0.29 |
| Sales/Fixed Asset(x) | 11.55 | 8.43 | 5.68 | 9.77 | 32.72 |
| Working Capital/Sales(x) | 0.89 | 0.99 | 0.80 | 0.92 | 0.95 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.09 | 0.12 | 0.18 | 0.10 | 0.03 |
| Receivable days | 32.03 | 31.23 | 30.70 | 28.50 | 27.72 |
| Inventory Days | 44.36 | 39.38 | 42.89 | 40.83 | 36.25 |
| Payable days | 119.32 | 130.52 | 159.09 | 164.16 | 181.45 |
| Valuation Parameters | |||||
| PER(x) | 13.50 | - | 65.18 | 122.97 | 32.69 |
| PCE(x) | 12.75 | 245.74 | 41.21 | 53.38 | 30.80 |
| Price/Book(x) | 1.80 | 2.10 | 1.91 | 1.71 | 2.22 |
| Yield(%) | 8.40 | 1.69 | 1.81 | 1.99 | 1.46 |
| EV/Net Sales(x) | 2.22 | 2.35 | 2.26 | 1.50 | 2.20 |
| EV/Core EBITDA(x) | 6.81 | 15.58 | 14.42 | 13.65 | 11.93 |
| EV/EBIT(x) | 7.16 | 930.30 | 18.09 | 18.77 | 12.37 |
| EV/CE(x) | 0.41 | 0.47 | 0.39 | 0.53 | 0.54 |
| M Cap / Sales | 3.68 | 3.64 | 3.57 | 2.83 | 3.45 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -5.28 | 4.86 | -12.98 | -10.69 | -12.98 |
| Core EBITDA Growth(%) | 104.30 | 0.70 | 24.31 | -46.80 | -45.32 |
| EBIT Growth(%) | - | -97.88 | 36.23 | -59.90 | -46.42 |
| PAT Growth(%) | 2,878.49 | -117.80 | 107.34 | -80.53 | -33.93 |
| EPS Growth(%) | 2,878.48 | -117.80 | 107.34 | -80.53 | -33.93 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 2.93 | 2.47 | 2.58 | 2.39 | 2.69 |
| Quick Ratio(x) | 2.73 | 2.30 | 2.45 | 2.25 | 2.53 |
| Interest Cover(x) | 66.93 | 0.21 | 6.21 | 5.48 | 54.94 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of NOVARTIS INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NOVARTIS INDIA | ₹2,534.7 Cr | 3.9% | 2.7% | 80.7% | Stock Analytics | |
| ADANI ENTERPRISES | ₹346,885.0 Cr | 1.8% | -4.9% | 70.2% | Stock Analytics | |
| REDINGTON | ₹17,230.3 Cr | 2.5% | -1.3% | 27% | Stock Analytics | |
| HONASA CONSUMER | ₹13,842.0 Cr | NA | NA | NA | Stock Analytics | |
| MMTC | ₹11,307.0 Cr | 1.5% | -21.7% | 117.1% | Stock Analytics | |
| MSTC | ₹6,180.8 Cr | 1.9% | -10.7% | 225.8% | Stock Analytics | |
NOVARTIS INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NOVARTIS INDIA | 3.9% |
2.7% |
80.7% |
| SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses
